MedTrace Logo

Improving Safety by Basic Computerizing Outpatient Prescribing

NCT01091038 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2023-10-12

No results posted yet for this study

Summary

The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.

Conditions

  • Adverse Drug Events

Interventions

OTHER

Basic Clinical Decision Support

The computerized physician order entry (CPOE) intervention provides physicians with a menu of medications from the formulary, default doses, and a range of potential doses for each medication. Physicians were required to enter dosage, route, and frequency for all orders. Also, CPOE ensured that all orders were legible and included the prescribing physician's signature. For a number of medications, the system displayed relevant laboratory results on the screen at the time of ordering. Other features included consequent orders, which are orders that should follow from other orders, and drug-allergy checking, drug-drug interaction checking, and drug-laboratory checking. This included checking for the most frequent drug allergies, about 80 carefully selected drug-drug interactions, and several drug-laboratory combinations

OTHER

Routine Care

Routine Care

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Indiana University

    lead OTHER

Principal Investigators

  • Joseph M Overhage, MD, PhD · Indiana University

  • David Bates, MD · Brigham and Women's Hospital

  • Tejal Gandhi, MD · Brigham and Women's Hospital

  • Andrew Seger, PharmD · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091038 on ClinicalTrials.gov